1 December 2016 -
16:30 to 17:45

The Economic Value of Medtech: Is This the New Era for a Partnership between Industry and Payers? (pdf)

Market Access & Regulatory

Studio 1

The 4th industrial revolution requires the ability to interact with several different stakeholders, moving beyond the cost of innovative products to concentrate on the value for the patient, the health care systems and society. The aim of this session will be to investigate and compare both the Industry’s and the Payers’ perspective regarding the value in general and the economic value in particular of Medtech, discussing the evidence requirements, their assessment and the collaboration in gathering these data to inform the financing and to leverage it as a new area to build a partnership.

Executive Director - The International Association of Non-profit Healthcare Payers (AIM)
Director Market Access and Economic Policies - MedTech Europe
Chairman of the Board of Directors - Hospital AZ Maria Middelares, Ghent (BE)
Professor of Medical Technology - Ghent University
Partner, Market Access Strategy & Health Economics Group - Deloitte Consulting CVBA